Patent · US Active

Antibodies recognizing tau

US10961302B2 · kind B2 · utility

6Cited by

6References

38Claims

0Family size

Assignee

Prothena Biosciences Limited · IE

Inventors

Tarlochan S. Nijjar · Orinda, US
Robin Barbour · Newark, US
Philip James Dolan, III · Foster City, US
Yue Liu · Foster City, US
Svetlana Alexander · Sunnyvale, US
Mark E. Renz · Millbrae, US

Key dates

Filing date	Mar 3, 2020
Grant date	Mar 30, 2021
Priority date	—
Expiry date	Mar 3, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.